vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and RCI HOSPITALITY HOLDINGS, INC. (RICK). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $70.9M, roughly 1.1× RCI HOSPITALITY HOLDINGS, INC.). RCI HOSPITALITY HOLDINGS, INC. runs the higher net margin — -7.8% vs -9.6%, a 1.8% gap on every dollar of revenue. On growth, RCI HOSPITALITY HOLDINGS, INC. posted the faster year-over-year revenue change (-3.1% vs -16.8%). Over the past eight quarters, RCI HOSPITALITY HOLDINGS, INC.'s revenue compounded faster (-2.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

RCI Hospitality Holdings, Inc., through its subsidiaries, operates strip clubs, nightclubs, sports bars/restaurants, and a media and convention company that serves the adult club industry. RCI went public with an IPO in 1995 is listed on The NASDAQ Global Market under the symbol RICK.

BIOX vs RICK — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.1× larger
BIOX
$77.6M
$70.9M
RICK
Growing faster (revenue YoY)
RICK
RICK
+13.7% gap
RICK
-3.1%
-16.8%
BIOX
Higher net margin
RICK
RICK
1.8% more per $
RICK
-7.8%
-9.6%
BIOX
Faster 2-yr revenue CAGR
RICK
RICK
Annualised
RICK
-2.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
RICK
RICK
Revenue
$77.6M
$70.9M
Net Profit
$-7.4M
$-5.5M
Gross Margin
46.8%
Operating Margin
9.3%
-0.7%
Net Margin
-9.6%
-7.8%
Revenue YoY
-16.8%
-3.1%
Net Profit YoY
-20.2%
-2354.9%
EPS (diluted)
$-0.12
$-0.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
RICK
RICK
Q3 25
$77.6M
$70.9M
Q2 25
$71.1M
Q1 25
$60.6M
$65.9M
Q4 24
$98.8M
$71.5M
Q3 24
$93.3M
$73.2M
Q2 24
$76.2M
Q1 24
$84.0M
$72.3M
Q4 23
$140.2M
$73.9M
Net Profit
BIOX
BIOX
RICK
RICK
Q3 25
$-7.4M
$-5.5M
Q2 25
$4.1M
Q1 25
$-1.6M
$3.2M
Q4 24
$605.2K
$9.0M
Q3 24
$-6.2M
$244.0K
Q2 24
$-5.2M
Q1 24
$9.8M
$774.0K
Q4 23
$1.2M
$7.2M
Gross Margin
BIOX
BIOX
RICK
RICK
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Q4 23
36.7%
Operating Margin
BIOX
BIOX
RICK
RICK
Q3 25
9.3%
-0.7%
Q2 25
12.2%
Q1 25
1.5%
12.4%
Q4 24
14.5%
19.5%
Q3 24
2.5%
4.8%
Q2 24
-3.3%
Q1 24
15.7%
6.4%
Q4 23
12.0%
17.8%
Net Margin
BIOX
BIOX
RICK
RICK
Q3 25
-9.6%
-7.8%
Q2 25
5.7%
Q1 25
-2.6%
4.9%
Q4 24
0.6%
12.6%
Q3 24
-6.6%
0.3%
Q2 24
-6.9%
Q1 24
11.6%
1.1%
Q4 23
0.9%
9.8%
EPS (diluted)
BIOX
BIOX
RICK
RICK
Q3 25
$-0.12
$-0.60
Q2 25
$0.46
Q1 25
$-0.02
$0.36
Q4 24
$0.00
$1.01
Q3 24
$-0.10
$0.04
Q2 24
$-0.56
Q1 24
$0.14
$0.08
Q4 23
$0.00
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
RICK
RICK
Cash + ST InvestmentsLiquidity on hand
$15.5M
$33.7M
Total DebtLower is stronger
$238.2M
Stockholders' EquityBook value
$288.3M
$261.1M
Total Assets
$734.9M
$596.9M
Debt / EquityLower = less leverage
0.91×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
RICK
RICK
Q3 25
$15.5M
$33.7M
Q2 25
$29.3M
Q1 25
$38.5M
$32.7M
Q4 24
$29.2M
$34.7M
Q3 24
$32.3M
$32.4M
Q2 24
$34.9M
Q1 24
$16.4M
$20.0M
Q4 23
$24.4M
$21.2M
Total Debt
BIOX
BIOX
RICK
RICK
Q3 25
$238.2M
Q2 25
$243.8M
Q1 25
$244.1M
Q4 24
Q3 24
$241.1M
Q2 24
Q1 24
Q4 23
Stockholders' Equity
BIOX
BIOX
RICK
RICK
Q3 25
$288.3M
$261.1M
Q2 25
$269.5M
Q1 25
$345.0M
$268.8M
Q4 24
$346.3M
$269.0M
Q3 24
$346.0M
$263.4M
Q2 24
$271.2M
Q1 24
$348.5M
$285.8M
Q4 23
$335.3M
$286.6M
Total Assets
BIOX
BIOX
RICK
RICK
Q3 25
$734.9M
$596.9M
Q2 25
$597.4M
Q1 25
$798.2M
$589.8M
Q4 24
$835.2M
$586.2M
Q3 24
$827.3M
$584.4M
Q2 24
$601.0M
Q1 24
$836.1M
$609.9M
Q4 23
$819.5M
$619.2M
Debt / Equity
BIOX
BIOX
RICK
RICK
Q3 25
0.91×
Q2 25
0.90×
Q1 25
0.91×
Q4 24
Q3 24
0.92×
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
RICK
RICK
Operating Cash FlowLast quarter
$14.4M
$13.7M
Free Cash FlowOCF − Capex
$11.5M
FCF MarginFCF / Revenue
16.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$34.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
RICK
RICK
Q3 25
$14.4M
$13.7M
Q2 25
$13.8M
Q1 25
$23.3M
$8.5M
Q4 24
$-5.4M
$13.3M
Q3 24
$5.2M
$15.7M
Q2 24
$15.8M
Q1 24
$-17.4M
$10.8M
Q4 23
$21.1M
$13.6M
Free Cash Flow
BIOX
BIOX
RICK
RICK
Q3 25
$11.5M
Q2 25
$10.1M
Q1 25
$5.7M
Q4 24
$7.6M
Q3 24
$10.3M
Q2 24
$9.3M
Q1 24
$3.2M
Q4 23
$8.5M
FCF Margin
BIOX
BIOX
RICK
RICK
Q3 25
16.2%
Q2 25
14.2%
Q1 25
8.6%
Q4 24
10.6%
Q3 24
14.0%
Q2 24
12.3%
Q1 24
4.4%
Q4 23
11.5%
Capex Intensity
BIOX
BIOX
RICK
RICK
Q3 25
3.2%
Q2 25
5.2%
Q1 25
4.3%
Q4 24
8.0%
Q3 24
7.3%
Q2 24
8.4%
Q1 24
10.6%
Q4 23
6.9%
Cash Conversion
BIOX
BIOX
RICK
RICK
Q3 25
Q2 25
3.40×
Q1 25
2.65×
Q4 24
-8.85×
1.48×
Q3 24
64.14×
Q2 24
Q1 24
-1.78×
14.00×
Q4 23
17.05×
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

RICK
RICK

Transferred At Point In Time$60.8M86%
Food And Merchandise$10.4M15%

Related Comparisons